首页> 外国专利> Compound, pharmaceutical composition, method for treating illness, for treating and / or preventing conditions mediated by nuclear receptors, and for the treatment and / or prevention of diabetes and / or obesity, use of a compound, and, method for treating type i diabetes, type ii diabetes, impaired glucose tolerance, insulin resistance or obesity

Compound, pharmaceutical composition, method for treating illness, for treating and / or preventing conditions mediated by nuclear receptors, and for the treatment and / or prevention of diabetes and / or obesity, use of a compound, and, method for treating type i diabetes, type ii diabetes, impaired glucose tolerance, insulin resistance or obesity

机译：化合物，药物组合物，疾病的治疗方法，用于治疗和/或预防核受体介导的病症以及用于治疗和/或预防糖尿病和/或肥胖症的化合物，化合物的用途以及用于治疗i型糖尿病的方法，II型糖尿病，葡萄糖耐量受损，胰岛素抵抗或肥胖

页面导航

摘要
著录项
相似文献

摘要

"COMPOUND, PHARMACEUTICAL COMPOSITION, METHODS FOR THE TREATMENT OF SICKNESS, FOR THE TREATMENT AND / OR PREVENTION OF CONDITIONS MEDIATED BY NUCLEAR RECEPTORS, AND FOR THE TREATMENT AND / OR PREVENTION OF DIABETES AND / OR OBESITY FOR THE USE OF A COMPOUND, AND TREAT TYPE I DIABETES, TYPE II DIABETES, TOLERANCE TO HARMED GLUCOSE, INSULIN RESISTANCE OR OBESITY ". The present invention relates to compounds of the general formula (I). The compounds are useful in the treatment and / or prevention of conditions mediated by nuclear receptors, in particular peroxisome proliferator activated receptors (PPAR).

机译：“化合物，药物成分，疾病的治疗方法，核受体介导的病状的治疗和/或预防，糖尿病和/或肥胖症的治疗和/或肥胖症的治疗和治疗“ I型糖尿病，II型糖尿病，葡萄糖的耐受性，胰岛素抵抗或肥胖”。本发明涉及通式（I）的化合物。所述化合物可用于治疗和/或预防由核受体，特别是过氧化物酶体增殖物激活的受体（PPAR）介导的病症。

著录项

公开/公告号BR0107901A

专利类型
公开/公告日2002-11-05

原文格式PDF
申请/专利权人 NOVO NORDISK A/S;
展开▼

申请/专利号BR20010107901
发明设计人 JOHN PATRICK MOGENSEN;PER SAUERBERG;PAUL STANLEY BURY;LONE JEPPESEN;INGRID PETTERSSON;
展开▼

申请日2001-01-26
分类号C07C69/708;C07C59/64;C07D213/55;C07D307/80;C07D317/54;C07D215/14;C07D307/40;A61K31/435;A61K31/34;A61K31/357;A61P3/04;A61P3/10;
国家 BR
入库时间 2022-08-22 00:46:02

相似文献

专利
外文文献
中文文献